The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Excessive Daytime Sleepiness Market From 2026 To 2030?
The excessive daytime sleepiness market size has seen robust expansion in recent years. It is projected to expand from $5.39 billion in 2025 to $5.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. This historical growth can be attributed to several factors, including an increasing prevalence of sleep disorders, a heightened awareness of sleep health impacts, the development of sleep clinic infrastructure, the availability of pharmacological wake-promoting agents, and the broader expansion of diagnostic sleep testing services.
The excessive daytime sleepiness market size is projected to experience substantial growth in the upcoming years, with an expectation to reach $8.52 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This expansion over the forecast period is primarily driven by factors such as the escalating demand for personalized sleep treatment plans, the growing integration of digital therapeutics into sleep care, the broadening adoption of remote patient monitoring, an increasing emphasis on preventive sleep healthcare, and rising investments in sleep medicine research. Significant trends anticipated during this forecast period include the expanding adoption of wearable sleep monitoring devices, the increasing utilization of combination therapy approaches, the widespread development of home-based sleep disorder management solutions, a heightened focus on early diagnosis and screening programs, and the enhanced integration of digital sleep health platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33109&type=smp
Which Economic Or Industry Drivers Are Impacting The Excessive Daytime Sleepiness Market?
An increase in obstructive sleep apnea (OSA) cases is anticipated to boost the excessive daytime sleepiness (EDS) market’s expansion moving ahead. Obstructive sleep apnea is defined as a sleep condition marked by recurrent breathing interruptions while sleeping, caused by an obstructed upper airway, which results in disrupted sleep and diminished sleep quality. The increasing occurrence of obstructive sleep apnea stems from escalating obesity rates, wherein excess fat around the neck and throat constricts the airway, prompting breathing pauses during sleep. Excessive daytime sleepiness is a prevalent and debilitating indicator of obstructive sleep apnea, frequently remaining present in a considerable number of patients, thus necessitating specific therapeutic and management approaches. For example, data from August 2026, provided by the National Library of Medicine, a US-based medical library, projects that by 2050, roughly 76.6 million adults in the United States, aged 30–69, will likely suffer from obstructive sleep apnea. This increasing incidence of obstructive sleep apnea is thus a key factor propelling the growth of the excessive daytime sleepiness market.
Which Segments Are Included In The Analysis Of The Excessive Daytime Sleepiness Market?
The excessive daytime sleepiness market covered in this report is segmented –
1) By Treatment Type: Pharmacological Treatment; Behavioral Therapy; Continuous Positive Airway Pressure Therapy; Lifestyle Modification Programs; Combination Therapies
2) By Diagnosis Method: Polysomnography; Multiple Sleep Latency Test; Actigraphy; Clinical Evaluation; Questionnaire Based Assessments
3) By Type Of Disorder: Narcolepsy; Obstructive Sleep Apnea; Insomnia; Circadian Rhythm Disorders; Idiopathic Hypersomnia; Restless Legs Syndrome; Other Type Of Disorders
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospitals; Sleep Clinics; Ambulatory Surgical Centers; Home Care Settings
Subsegments:
1) By Pharmacological Treatment: Wake Promoting Medications; Central Nervous System Stimulant Medications; Dopamine Reuptake Inhibitor Medications; Histamine Receptor Modulating Medications
2) By Behavioral Therapy: Cognitive Behavioral Therapy For Sleep; Sleep Hygiene Education Programs; Stimulus Control Therapy; Sleep Restriction Therapy
3) By Continuous Positive Airway Pressure Therapy: Fixed Pressure Airway Therapy; Auto Adjusting Airway Therapy; Bilevel Airway Therapy; Adaptive Pressure Support Therapy
4) By Lifestyle Modification Programs: Sleep Schedule Regulation Programs; Diet And Nutrition Management Programs; Physical Activity And Exercise Programs; Stress Management And Relaxation Programs
5) By Combination Therapies: Medication And Behavioral Therapy Combinations; Airway Therapy And Lifestyle Modification Combinations; Medication And Airway Therapy Combinations; Integrated Multimodal Treatment Approaches
Which Trends Are Impacting The Growth Of The Excessive Daytime Sleepiness Market?
Leading firms within the excessive daytime sleepiness market are concentrating on creating novel treatments, including central nervous system depressants, aimed at boosting wakefulness and elevating patients’ quality of life. A central nervous system depressant is defined as a compound that diminishes nervous system function, leading to effects like sedation, tranquility, or sleepiness. For example, in September 2025, Amneal Pharmaceuticals Inc., a pharmaceutical company based in the US, secured FDA approval for its sodium oxybate oral solution, a product designed to directly address excessive daytime sleepiness (EDS) in individuals with narcolepsy. This solution aids in maintaining continuous treatment by enabling virtual consultations with specialists, remote dispensing of prescriptions, and broader patient access in areas lacking adequate services. Its goal is to broaden availability, make treatment more affordable, and integrate existing drug therapies with contemporary digital and telehealth approaches to care for excessive daytime sleepiness.
Who Are The Top Companies Competing In The Excessive Daytime Sleepiness Market?
Major companies operating in the excessive daytime sleepiness market are Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cleveland Clinic, EisAI Co. Ltd, Jazz Pharmaceuticals plc., Emory Healthcare Inc., Alkermes plc., Fisher & Paykel Healthcare Corporation Limited, Harmony Biosciences Holdings Inc., Medanta, Axsome Therapeutics Inc., Compumedics Limited, BIOPROJET, Apnimed Inc., Nox Health Inc., Somnogen Canada Inc., Suven Life Sciences Limited, Theranexus, XWPharma, NLS Pharmaceutics AG.
Read the full excessive daytime sleepiness market report here:
https://www.thebusinessresearchcompany.com/report/excessive-daytime-sleepiness-market-report
Which Global Regions Are Shaping The Competitive Landscape Of The Excessive Daytime Sleepiness Market?
North America was the largest region in the excessive daytime sleepiness market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the excessive daytime sleepiness market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Excessive Daytime Sleepiness Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33109&type=smp
Browse Through More Reports Similar to the Global Excessive Daytime Sleepiness Market 2026, By The Business Research Company
Insomnia Market Report 2026
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report
Sleep Testing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report
Sleep Monitoring Apps Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-monitoring-apps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model